3 In the index

Arimistane ARIMI

An over-the-counter supplement marketed to control estrogen after a steroid cycle, a milder relative of prescription estrogen-blocking drugs. It has much less independent research behind it than the pharmaceutical versions, and is generally considered a weaker, less-proven option.

Also known as Androstenetrione, Androsta-3,5-diene-7,17-dione, 77P0LYX19T, RefChem:112632, Androst-3,5-diene-7,17-dione, 3,5-Androstadiene-7,17-dione, F87119, Q27266598

Effects Hormonal

Routes Oral

Legal status Unapproved / investigational

WADA Banned at all times

3D Molecular Structure of C₁₉H₂₄O₂

Drag to rotate · scroll to zoom

Chemistry

Formula: C19H24O2
Molar mass: 284.4
CAS: 1420-49-1
PubChem CID: 150910
IUPAC name: (8R,9S,10R,13S,14S)-10,13-dimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-7,17-dione
InChIKey: VHDOTNMSJDQVEE-ZENYQMPMSA-N

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 50-75 mg/day

Reported range 25-100 mg/day

Route Oral

Frequency 1-2 times daily

Duration 4-8 week cycles (post-cycle-therapy use)

Sold as an OTC supplement despite being a steroidal compound with hormonal activity; not FDA-approved as a drug, and its supplement status has been challenged by regulators in some markets.

Where this comes from User-reported/supplement-industry dosing

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.